BDBM698802 (4-(4,4-difluoropiperidin-1-yl)-2-((1- ((dimethylamino)methyl)cyclopropyl) methoxy)-5,7-dihydro-6H-pyrrolo [3,4-d]pyrimidin-6-yl)(3-hydroxy-8- iodonaphthalen-1-yl)methanone::US20240317759, Example 12

SMILES C[C@]1(O)C[C@]2(CCN2C(=O)c2cnc(N[C@H]3Cc4cc(Cl)cc(C#N)c4C3)nc2)C1

InChI Key InChIKey=BBFIXKSFBFZWRR-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 698802   

TargetAutotaxin(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 698802BDBM698802((cis)-6-chloro-2-(S)- ((5-(6-hydroxy-6- methyl-1- ...)
Affinity DataIC50: 5.5nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2026
Entry Details
US Patent